A $10M+ R&D bet. Forty buyers made it a board-ready decision.
Product Strategy
Product Strategy
Objective
A PE-backed life sciences tools company needed to decide whether to greenlight development of a next-generation integrated platform. Carl's team ran demand validation across forty prospective buyers and delivered a go recommendation grounded in quantitative evidence, competitive positioning, and internal feasibility.
Our Approach
Outcome
Related Client Results
MRD Monitoring Market Assessment and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing
Diagnostic Advisory Board
Voice-of-Customer Research
KOL Identification
AdBoards
Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
